Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
ROIV Roivant Sciences Ltd
- Stocks
- Healthcare
- NASDAQ: ROIV
Price (delayed)
$10.99
Market cap
$7.47B
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.24
Enterprise value
$4.86B
Highlights
The company's gross margin rose by 3.1% QoQ
The company's quick ratio rose by 34% YoY but it fell by 10% QoQ
The net income has dropped by 104% year-on-year and by 47% since the previous quarter
The EPS has shrunk by 104% YoY and by 26% QoQ
Key stats
What are the main financial stats of ROIV
Market
Valuations
Earnings
Shares outstanding
679.81M
Market cap
$7.47B
Enterprise value
$4.86B
Price to earnings (P/E)
N/A
Price to book (P/B)
1.67
Price to sales (P/S)
274.4
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
167.14
Revenue
$29.05M
Gross profit
$28.14M
Operating income
-$1B
Net income
-$171.98M
EBIT
-$123.81M
EBITDA
-$102.89M
Free cash flow
-$844.05M
Per share
Balance sheet
Liquidity
EPS
-$0.24
EPS diluted
-$0.24
Free cash flow per share
-$1.16
Book value per share
$6.57
Revenue per share
$0.04
TBVPS
$7.5
Total assets
$5.44B
Total liabilities
$249.74M
Debt
$100.17M
Equity
$4.69B
Working capital
$4.85B
Debt to equity
0.02
Current ratio
33.47
Quick ratio
32.71
Net debt/EBITDA
25.42
Margins
Efficiency
Dividend
EBITDA margin
-354.2%
Gross margin
96.9%
Net margin
-592%
Operating margin
-3,453.3%
Return on assets
-2.9%
Return on equity
-3.4%
Return on invested capital
-4.5%
Return on capital employed
-2.3%
Return on sales
-426.1%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
ROIV stock price
How has the Roivant Sciences stock price performed over time
Intraday
0.18%
1 week
-5.26%
1 month
-2.27%
1 year
4.87%
YTD
-7.1%
QTD
-2.48%
Financial performance
How have Roivant Sciences's revenue and profit performed over time
Revenue
$29.05M
Gross profit
$28.14M
Operating income
-$1B
Net income
-$171.98M
Gross margin
96.9%
Net margin
-592%
ROIV's operating margin has dropped by 184% since the previous quarter and by 125% year-on-year
ROIV's operating income has dropped by 122% year-on-year and by 6% since the previous quarter
The net income has dropped by 104% year-on-year and by 47% since the previous quarter
The net margin has dropped by 104% year-on-year
Price vs fundamentals
How does ROIV's price correlate with its fundamentals
Growth
What is Roivant Sciences's growth rate over time
Valuation
What is Roivant Sciences stock price valuation
P/E
N/A
P/B
1.67
P/S
274.4
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
167.14
The EPS has shrunk by 104% YoY and by 26% QoQ
The stock's price to book (P/B) is 81% less than its 5-year quarterly average of 8.8 but 4.4% more than its last 4 quarters average of 1.6
ROIV's equity is down by 21% year-on-year and by 10% since the previous quarter
The stock's price to sales (P/S) is 97% more than its last 4 quarters average of 139.0 and 79% more than its 5-year quarterly average of 153.6
Roivant Sciences's revenue has shrunk by 63% QoQ and by 11% YoY
Efficiency
How efficient is Roivant Sciences business performance
The ROS has shrunk by 103% YoY
ROIV's return on assets has dropped by 103% year-on-year and by 61% since the previous quarter
The ROE has shrunk by 103% YoY and by 62% QoQ
The ROIC has plunged by 101% YoY but it has grown by 8% from the previous quarter
Dividends
What is ROIV's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for ROIV.
Financial health
How did Roivant Sciences financials performed over time
ROIV's total liabilities has dropped by 68% year-on-year and by 2.6% since the previous quarter
The company's quick ratio rose by 34% YoY but it fell by 10% QoQ
The debt is 98% smaller than the equity
The debt to equity has surged by 100% year-on-year
The debt has surged by 86% year-on-year
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.